ZEPBOUND
NDC 0002-2484 · Eli Lilly and Company
Generic nametirzepatide
Dosage formINJECTION, SOLUTION
RouteSUBCUTANEOUS
Active ingredient(s)TIRZEPATIDE
Strength7.5 mg/.5mL
Pharmacologic classG-Protein-linked Receptor Interactions [MoA], GLP-1 Receptor Agonist [EPC], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA], Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC]
Marketing categoryNDA
Packages
0002-2484-80 — 4 SYRINGE in 1 CARTON (0002-2484-80) / .5 mL in 1 SYRINGE (0002-2484-01)
Related Codes
Same active ingredient
FDA lists these products with the same active ingredient.
0002-1484 — tirzepatide, 0002-1495 — tirzepatide, 0002-1506 — tirzepatide, 0002-2002 — tirzepatide, 0002-2214 — tirzepatide, 0002-2340 — tirzepatide, 0002-2423 — tirzepatide, 0002-2457 — tirzepatide, 0002-2460 — tirzepatide, 0002-2471 — tirzepatide, 0002-2495 — tirzepatide, 0002-2506 — tirzepatide, 0002-3002 — tirzepatide, 0002-3411 — tirzepatide, 0002-3422 — tirzepatide, 0002-3433 — tirzepatide, 0002-3444 — tirzepatide, 0002-3455 — tirzepatide, 0002-3466 — tirzepatide, 0002-3511 — tirzepatide, +33 more